NASDAQ:ADXS
Delisted

Advaxis Stock Predictions

etoro logo Buy ADXS
*Your capital is at risk
$0.604
+0 (+0%)
At Close: May 01, 2026
Currently predicting for Mon, 8 Jun 2026

ADXS Prediction Chart

ADXS Predictions History

Latest community submissions for ADXS.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jul 26, 2021 $0.406 -98.76% $0.408 V 99.44% 4
Jul 26, 2021 $0.400 -98.78% $0.408 V 97.97% 1
Jul 7, 2021 Bullish $0.507 X 0
Cherie Lynn Auletta Cherie Lynn Auletta @CherieLynnAuletta.210168
Jul 7, 2021 Bearish $0.507 V 1
Jul 7, 2021 Bearish $0.507 V 1
JS JS Pro
Jan 20, 2021 $0.698 -98.74% $0.692 V 99.13% 3
Baltzera Baltzera Merchant
Jan 20, 2021 Bearish $0.692 V 1
JS JS Pro
Jan 19, 2021 $0.593 -98.97% $0.718 V 82.64% 0
Jan 19, 2021 Bullish $0.718 X 1
JS JS Pro
Nov 12, 2020 $0.393 -98.75% $0.394 V 99.67% 5
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ADXS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ADVAXIS
Advaxis
Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE